Penile Cancer-A Preventable Cause of Death in Elderly Men

Penile cancer incidence is rising in wealthy countries, mortality peaks in men 75+, and two treatable precursor conditions drive most cases

Journal: British Journal of Hospital Medicine | Published: 2026-03-13 | Type: Narrative Review | PMID: 41914004 Authors: Uppal Encarl (Chelsea and Westminster Hospital), Kravvas Georgios, Alnajjar Hussain, Muneer Asif, Bunker Christopher (University College London Hospitals / UCL) Funding/COI: Not listed

Summary

Penile cancer (PeCa) predominantly strikes men over 75, and its incidence is climbing in high-income countries. Two converging risk factors — male genital lichen sclerosus (MGLSc) and persistent high-risk HPV infection — drive the majority of cases through distinct molecular pathways. The authors argue that most of this mortality is preventable through earlier recognition of precursor lesions, HPV vaccination, circumcision, and smoking cessation.

Claims

• Incidence of penile cancer is rising in high-income countries; mortality burden falls disproportionately on men aged 75 and older
• Two principal carcinogenic pathways: HPV-dependent (→ undifferentiated penile intraepithelial neoplasia → squamous cell carcinoma) and HPV-independent (chronic MGLSc-driven inflammation → differentiated PeIN → SCC)
• MGLSc and high-risk HPV are identified as the two major, synergistic risk factors
• Additional modifiable risk factors include phimosis, smoking, and poor genital hygiene
• Prognosis is closely tied to lymph node involvement
• Preventive interventions — early MGLSc and PeIN treatment, HPV vaccination, circumcision, smoking cessation — could "substantially reduce disease burden"

Study Quality

This is a narrative review, not a systematic review or meta-analysis, which limits its evidentiary weight. The authors state they prioritised "high-impact studies and recent advances," but without a registered protocol, predefined inclusion criteria, or a PRISMA flow diagram, there is no way to verify the literature selection isn't shaped by pre-existing views. Narrative reviews are inherently prone to selective citation and confirmation bias.

The paper covers an unusually wide scope — epidemiology, pathogenesis, diagnosis, management, and prevention — in a single article. Each section is necessarily a cursory overview. No specific incidence figures, absolute risk estimates, or effect sizes appear in the abstract; claims like "rising incidence" and "substantially reduce disease burden" are asserted without quantification.

Red Flags

• Narrative review design: no systematic search strategy, no PRISMA, no reproducible methodology
• Funding and conflicts of interest are not declared — a significant omission for a clinically oriented paper covering circumcision, HPV vaccination, and surgical management
• Key epidemiological claims ("rising incidence," "substantially reduce") are unquantified — no incidence rates, no attributable risk fractions
• Breadth of scope (full clinical spectrum in one article) necessarily sacrifices depth throughout

Strengths

• Clinically underserved population: elderly men with penile cancer receive scant dedicated literature attention
• Dual-pathway model (HPV-dependent vs. MGLSc-driven SCC) is a useful conceptual framework, explaining why HPV vaccination alone won't eliminate penile cancer
• UCL and Chelsea & Westminster have established expertise in penile disease; author group includes recognised names in the field
• Covers the full spectrum from precursor management to emerging immunotherapies, making it a reasonable orientation document

Verdict

A competent but methodologically lightweight narrative review. The dual-pathway carcinogenesis model is the most clinically useful takeaway: it makes clear that MGLSc surveillance and treatment is not interchangeable with HPV vaccination — both are needed, targeting different disease routes. The paper's prevention framing is appropriate given that every listed risk factor is modifiable. But the absence of declared conflicts, hard incidence numbers, and a systematic literature method means this is expert opinion dressed as evidence synthesis. Cite it for the conceptual framework; don't lean on it for quantitative claims.